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Technical Appendix 
Part 1: Laboratory methods for PCR detection of MERS-CoV and antibody 
detection 
Total RNA was extracted from 200 μL Universal Transport medium (COPAN) by 
using the High Pure RNA isolation kit (Roche, Mannheim, Germany) and tested for MERS-
CoV RNA by internally controlled real-time reverse transcription PCR targeting Orf1A, 
nucleocapsid, and UpE with the TaqMan Fast Virus 1-Step Master Mix (Applied Biosystems, 
Bleiswijk, the Netherlands) as described (1–3). The results were independently confirmed in 2 
laboratories (RIVM and Erasmus MC) and samples were considered MERS-CoV positive 
when at least 2 different MERS-CoV specific targets were reactive (4). 
Serum samples were tested in at a 1:20 dilution for IgG reactive with MERS-CoV 
(residues 1–747), severe acute respiratory syndrome–CoV (residues 1–676) and human 
coronavirus OC43 (residues 1–760) spike domain S1 antigens by using extensively validated 
protein-microarray technology, as described (3,5). Confirmation was performed by using a 
neutralization assay (4). 
Part 2: Questionnaire to assess knowledge, quality of information, perceptions 
of severity and vulnerability and interference of measures with daily life 
All contacts received an invitation by post including a link and a unique code to access 
an online questionnaire (Formdesk, Innovero Software Solutions B.V., The Hague, The 
Netherlands). The questionnaire contained precoded questions on demographics, type of 
contact, quality of information received, perceived severity and vulnerability, feelings of 
anxiety, perceived interference with daily life, and knowledge (including questions regarding 
travel advice for the travel group). The questionnaire was based on questionnaires used in 
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similar studies on severe acute respiratory syndrome, infection with avian influenza, infection 
with influenza A (H1N1) virus, and Marburg hemorrhagic fever (6–10), with some 
alterations. 
Questions on perceived severity and vulnerability, feelings of anxiety, and perceived 
interference with daily life (e.g., restrictions on social life and fear of becoming infected) were 
based on an integrated model designed to explain health behavior (11,12). Knowledge of 
MERS-CoV was examined with 7 true/false/don’t know statements. The members of the 
travel group (n = 29) were also asked to answer questions regarding the travel advice they had 
received before their trip to Saudi Arabia. The presence of concurrent conditions and use of 
medicines were not part of this questionnaire, but were addressed in another study and 
published elsewhere (13). The questionnaire took 15 min to fill out and the information was 
processed anonymously. 
Data Analysis 
Differences in knowledge, impact of monitoring measures, quality of information, and 
perception between unprotected and protected contacts were compared in contingency tables 
by using the 2 test. For assessing knowledge, a summary score was created on the basis of 
the number of correct answers (range 0–7). Significance was determined at the 5% level (p-
≤0.05). Data analysis was performed with SAS 9.3(SAS Institute, Cary, NC, USA). 
Results 
Demographics 
Of the 131 contacts, 72 (55%) filled out the questionnaire. Among the unprotected 
contacts, the response rate was highest for the travel group (22 [76%] of 29), compared with 
19 (59%) of 32 for the other unprotected contacts and 7 (41%) of 17 for the aircraft contacts. 
Among the protected contacts the response rate was 24 (45%) of 53. The median age of 
respondents was 39 years (range 9–77 years), 53% were female, and 51% had at least a 
college education. Protected contacts were younger (median of 31 years vs. 48 years) and had 
more education (88% bvs. 31%) than unprotected contacts. 
Knowledge of MERS-CoV 
Most (83%) contacts were aware of the symptoms related to MERS-CoV infection and 
knew that MERS-CoV is not common in the Netherlands (83%) (Table 1). In total, 76% of 
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the contacts knew that MERS-CoV could spread by having contact with a camel. Half of the 
contacts knew MERS-CoV can be transmitted from person to person. Half of the respondents 
knew that there is no specific treatment for MERS-CoV; one-third (36%) thought a vaccine 
was available. On the knowledge sum score, protected contacts (5.1, 95% CI 4.5–5.6) scored 
significantly higher than unprotected contacts (3.8, 95% CI 3.3–4.3). 
Perception of MERS-CoV and Interference of the Measures with Daily Life 
Perception 
Most contacts (n = 54; 75%) perceived MERS-CoV as being (very) serious (Table 2). 
In addition, 69% of contacts (n = 50) thought MERS-CoV would have a (very) negative 
impact on their health. However, only 49% (n = 35) of the persons thought about MERS-CoV 
(very) often in the last month. Unprotected contacts thought significantly more often about 
MERS-CoV than did protected contacts (p = 0.02). 
Interference of the Measures with Daily Life 
Only 4% (n = 3) of contacts regularly perceived measuring or reporting their 
temperature as a burden. Most contacts (90%, n = 65) were not planning to leave the 
Netherlands and 93% experienced no problems with this measure. Extra costs were involved 
for 21 (29%) of the contacts. Being identified as a contact caused anxiety in respondents, and 
38 (53%) of them were afraid of contracting MERS-CoV or infecting their families (53%, n = 
38). These numbers were higher for unprotected than protected contacts (69%, [n = 33] vs. 
21%, [n = 5] and 65%, [n = 31] vs. 29%, [n = 7]) respectively. Furthermore, approximately 
one-third of the contacts reported that their family members expressed anxiety about 
becoming infected (35%, n = 25). There were no protected contacts who felt seriously limited 
in their social contacts because of the measurements they had to take, compared with 16 
unprotected contacts (22%) who did feel limited. 
Information on MERS-CoV 
Written instructions with detailed information on the monitoring measures and their 
rationale were received by 53 (74%) of 72 respondents. Of these 53 respondents, 41 (77%) 
found the information to be clear, 33 (73%) complete, 30 (56%) unequivocal. Only 4 (8%) 
thought the information was confusing, and 2 (4%) thought it was redundant. In total, 25 
(47%) thought the information was clear, complete, and unequivocal. 
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Travel Advice 
Twenty-three of the 29 participants to the pilgrimage trip to Saudi Arabia filled out 
this part of the questionnaire; 21 (91%) received travel advice or vaccinations before the trip 
(the other 2 were already vaccinated, for example against meningococcal disease and DTP, 
because of previous traveling). During the pretravel consultation, only 1 person received 
information on the possible transmission of MERS-CoV in the Middle East (avoid contact 
with animals, avoid drinking unpasteurized milk, and when having symptoms contact a doctor 
when returning to the Netherlands). However, although most did not receive any advice, 8 
persons watched their health more carefully (35%), 9 reported that they were more compliant 
with personal hygiene measures during the trip (39%), 3 avoided contact with animals (13%), 
and 3 avoided contact with animals’ waste (13%). Twelve did not change their behavior after 
receiving travel advice (52%). 
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Table 1. Middle East respiratory syndrome coronavirus general knowledge among contacts (n = 72) stratified by protected vs. unprotected contacts, the Netherlands 2014 
Statement (correct answer) 
All contacts (n = 72) Unprotected contacts (n = 46) Protected contacts (n = 26) 
p value No. correct % Correct No. correct % Correct No. correct % Correct 
Patients with MERS have a fever, are coughing, are short of breath, have 
difficulties breathing and have diarrhea (true) 
60 83 37 77 23 96 0.04 
MERS is prevalent in the Netherlands (false) 60 83 38 79 22 92 0.20 
MERS is a bacterium causing severe lung disease (false) 13 18 6 13 7 31 0.08 
In the Middle East MERS can be contracted through contact with camels or 
their products such as meat, milk, urine or feces (true) 
55 76 34 71 21 88 0.11 
MERS can be spread from person to person (true) 36 50 20 42 16 69 0.05 
There is no specific treatment once you contract MERS (true) 36 50 24 50 12 50 1.00 
There is a vaccine available for MERS (false) 46 64 48 56 19 81 0.06 






Table 2. MERS-CoV general perception among all contacts (n = 72) and stratified by unprotected- vs. protected contacts, the Netherlands 2014 
Perception 
Total (n = 72) Unprotected contacts (n = 46) Protected contacts (n = 26) 
p value No. % No.  % No.  % 
MERS is (very) serious to contract 54 75 34 71 20 83 0.3 
MERS is (very) bad for my health 50 69 32 67 18 75 0.5 
I have thought about MERS (very) often 
in the last month 
35 49 28 60 7 29 0.02 
 
